by Don Bell, University of Alberta Graphical abstract. Credit: Journal of Autoimmunity (2024). DOI: 10.1016/j.jaut.2024.103267 Researchers at the University of Alberta have pinpointed two proteins that could serve as markers for identifying patients with long COVID—a discovery that may lead to treatments that will bring better quality of life for the millions of people suffering from the debilitating...
Tag: <span>Long Covid</span>
Post
Metformin: An Unexpected Ally Against Long COVID?
Metformin use in adults with type 2 diabetes (T2D) is associated with a slightly lower incidence of long COVID and death within 180 days after SARS-CoV-2 infection. METHODOLOGY: TAKEAWAY: IN PRACTICE: “The incidence of PASC was lower when defined by [International Classification of Diseases] code compared with a computable phenotype in both databases,” the authors...
Post
Study finds persistent infection could explain long COVID in some people
Brigham researchers have found that people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms. A persistent infection could explain why some people experience long COVID symptoms, according to a new study led by researchers at Brigham and Women’s Hospital. The team found...
Post
Long COVID patients with abnormal lung CT scans could prove key to preventing pulmonary fibrosis
Patients with RPRA exhibit fibrotic abnormalities on CT imaging that improve with time. Long COVID occurs in approximately a third of COVID-19 survivors, with the CDC estimating one in 13 adults in the United States have long COVID symptoms such as brain fog, shortness of breath and chest pain. In a new study published in Nature Immunology, pulmonologists...
Post
Routine lab tests are not a reliable way to diagnose long COVID, finds study
August 12, 2024 by NIH/National Heart, Lung and Blood Institute Credit: Pixabay/CC0 Public DomainA National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition. The study, part of NIH’s Researching COVID to Enhance Recovery (NIH...
Post
Paxlovid, Vitamin Supplements Show Promise With Long COVID
Medscape Medical News David Brzostowicki July 29, 2024 Paxlovid, an antiviral approved last year to treat acute infections of COVID-19, is showing great potential as a new treatment for long COVID and may be the most promising experimental therapy now being studied for treating the condition. New research offers strong evidence that Paxlovid provides significant...
Post
Success in treating persistent pain now offers hope for those with long COVID
by Hamish Wilson and John Douglas Dunbar, The Conversation Credit: Andrea Piacquadio from PexelsThe emergence of long COVID as a mysterious new illness has refocused attention on the incapacitating nature of persistent fatigue. Around the world, this unexpected outcome of the pandemic is now a significant health issue causing considerable personal suffering, absences from work...
Post
Long COVID’s toll outlined in new report
JUNE 6, 2024 by Robin Foster Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty document released Wednesday, the National Academies of Sciences, Engineering and Medicine, a nongovernmental group that advises federal agencies on science and medicine, detailed...
Post
Low iron levels resulting from infection could be key trigger of long COVID
Peer-Reviewed PublicationUNIVERSITY OF CAMBRIDGE Problems with iron levels in the blood and the body’s ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger for long COVID, new research has discovered. The discovery not only points to possible ways to prevent or treat the condition, but could help...
Post
Study IDs Immune Abnormality Possibly Causing Long COVID
Tinker Ready Swiss scientists have identified immune system abnormalities in patients with long COVID that might open the door to new diagnostic tests and treatments. The researchers found that a group of proteins in the blood that are part of the body’s immune response called the “complement system” are not working properly in patients with...